XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab Dec 30, 2025 7:30am EST
XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V. Nov 21, 2025 7:45am EST
XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements Nov 12, 2025 7:30am EST
